155 related articles for article (PubMed ID: 17645698)
1. Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture.
García-Navarro A; González-Puga C; Escames G; López LC; López A; López-Cantarero M; Camacho E; Espinosa A; Gallo MA; Acuña-Castroviejo D
J Pineal Res; 2007 Sep; 43(2):195-205. PubMed ID: 17645698
[TBL] [Abstract][Full Text] [Related]
2. Luzindole but not 4-phenyl-2- propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro.
Winczyk K; Fuss-Chmielewska J; Lawnicka H; Pawlikowski M; Karasek M
Neuro Endocrinol Lett; 2009; 30(5):657-62. PubMed ID: 20035258
[TBL] [Abstract][Full Text] [Related]
3. Selective CCK-A but not CCK-B receptor antagonists inhibit HT-29 cell proliferation: synergism with pharmacological levels of melatonin.
González-Puga C; García-Navarro A; Escames G; León J; López-Cantarero M; Ros E; Acuña-Castroviejo D
J Pineal Res; 2005 Oct; 39(3):243-50. PubMed ID: 16150104
[TBL] [Abstract][Full Text] [Related]
4. Influence of melatonin on cell proliferation, antioxidative enzyme activities and lipid peroxidation in 3T3-L1 preadipocytes--an in vitro study.
Zwirska-Korczala K; Jochem J; Adamczyk-Sowa M; Sowa P; Polaniak R; Birkner E; Latocha M; Pilc K; Suchanek R
J Physiol Pharmacol; 2005 Dec; 56 Suppl 6():91-9. PubMed ID: 16340042
[TBL] [Abstract][Full Text] [Related]
5. Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo.
Winczyk K; Pawlikowski M; Lawnicka H; Kunert-Radek J; Spadoni G; Tarzia G; Karasek M
Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():50-4. PubMed ID: 12019352
[TBL] [Abstract][Full Text] [Related]
6. Growth-inhibitory action of melatonin and thiazolidinedione derivative CGP 52608 on murine 16/C breast cancer cells.
Winczyk K; Lawnicka H; Pawlikowski M; Kunert-Radek J; Karasek M
Neuro Endocrinol Lett; 2006 Jun; 27(3):351-4. PubMed ID: 16816834
[TBL] [Abstract][Full Text] [Related]
7. Intracellular second messengers involved in melatonin signal transduction in chicken splenocytes in vitro.
Markowska M; Mrozkowiak A; Pawlak J; Skwarło-Sońta K
J Pineal Res; 2004 Oct; 37(3):207-12. PubMed ID: 15357666
[TBL] [Abstract][Full Text] [Related]
8. Melatonin as a negative mitogenic hormonal regulator of human prostate epithelial cell growth: potential mechanisms and clinical significance.
Tam CW; Chan KW; Liu VW; Pang B; Yao KM; Shiu SY
J Pineal Res; 2008 Nov; 45(4):403-12. PubMed ID: 18637986
[TBL] [Abstract][Full Text] [Related]
9. Modification of nitric oxide synthase activity and neuronal response in rat striatum by melatonin and kynurenine derivatives.
León J; Vives F; Crespo E; Camacho E; Espinosa A; Gallo MA; Escames G; Acuña-Castroviejo D
J Neuroendocrinol; 1998 Apr; 10(4):297-302. PubMed ID: 9630400
[TBL] [Abstract][Full Text] [Related]
10. Melatonin binding sites in estrogen receptor-positive cells derived from human endometrial cancer.
Kobayashi Y; Itoh MT; Kondo H; Okuma Y; Sato S; Kanishi Y; Hamada N; Kiguchi K; Ishizuka B
J Pineal Res; 2003 Sep; 35(2):71-4. PubMed ID: 12887647
[TBL] [Abstract][Full Text] [Related]
11. Critical role of glutathione in melatonin enhancement of tumor necrosis factor and ionizing radiation-induced apoptosis in prostate cancer cells in vitro.
Sainz RM; Reiter RJ; Tan DX; Roldan F; Natarajan M; Quiros I; Hevia D; Rodriguez C; Mayo JC
J Pineal Res; 2008 Oct; 45(3):258-70. PubMed ID: 18384530
[TBL] [Abstract][Full Text] [Related]
12. Melatonin synthesized by Jurkat human leukemic T cell line is implicated in IL-2 production.
Lardone PJ; Carrillo-Vico A; Naranjo MC; De Felipe B; Vallejo A; Karasek M; Guerrero JM
J Cell Physiol; 2006 Jan; 206(1):273-9. PubMed ID: 16021634
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the cGMP signaling pathway by melatonin in pancreatic beta-cells.
Stumpf I; Bazwinsky I; Peschke E
J Pineal Res; 2009 Mar; 46(2):140-7. PubMed ID: 19175857
[TBL] [Abstract][Full Text] [Related]
14. Concomitant supplementation of lycopene and eicosapentaenoic acid inhibits the proliferation of human colon cancer cells.
Tang FY; Cho HJ; Pai MH; Chen YH
J Nutr Biochem; 2009 Jun; 20(6):426-34. PubMed ID: 18708285
[TBL] [Abstract][Full Text] [Related]
15. [Glutathione levels in human colon cancer cell line M7609 following culture in a low sulfur amino acid medium and its sensitivity to various anticancer drugs].
Saito T; Ikeda S; Hisai H; Katahira T; Kondo H; Takahashi Y; Takayama T
Gan To Kagaku Ryoho; 1997 May; 24(7):823-7. PubMed ID: 9170520
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic actions of melatonin in cancer: possible mechanisms.
Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
[TBL] [Abstract][Full Text] [Related]
17. Intracellular signaling pathways involved in cell growth inhibition of human umbilical vein endothelial cells by melatonin.
Cui P; Yu M; Luo Z; Dai M; Han J; Xiu R; Yang Z
J Pineal Res; 2008 Jan; 44(1):107-14. PubMed ID: 18078456
[TBL] [Abstract][Full Text] [Related]
18. New paradigms in chronic intestinal inflammation and colon cancer: role of melatonin.
Motilva V; García-Mauriño S; Talero E; Illanes M
J Pineal Res; 2011 Aug; 51(1):44-60. PubMed ID: 21752096
[TBL] [Abstract][Full Text] [Related]
19. Antioxidative potential of melatonin against mercury induced intoxication in spermatozoa in vitro.
Rao MV; Gangadharan B
Toxicol In Vitro; 2008 Jun; 22(4):935-42. PubMed ID: 18329842
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cell proliferation and invasion in a human colon cancer cell line by 5-aminosalicylic acid.
Kim YH; Kim MH; Kim BJ; Kim JJ; Chang DK; Son HJ; Rhee PL; Rhee JC
Dig Liver Dis; 2009 May; 41(5):328-37. PubMed ID: 18976971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
